Hits Parade — AlphaGalileo Top 5
Here it is - our hit parade that compiles the press releases with bigger number of visits in October 2011
1. Novel Tool for Myocardial Infarction Quantification: Step toward speeding the evaluation of novel therapies for heart regeneration — IBMC.INEB Associate Laboratory — 01/10/2011
An original tool to quantify the size of heart ischemia in pre-clinical animal models has been developed by a team of scientists from INEB-Instituto de Engenharia Biomédica. The MIQuant is user-friendly semi-automated software and is made freely available online to contribute towards the standardization and simplification of infarct size assessment.
Representative image of a mouse heart transverse-section following surgically induced myocardial infarction. The ischemic region, characterized by strong collagen deposition (blue), was highlighted with Masson’s Tricrome stain. The infarct size is regarded as a key parameter to assess the cardiac-regenerative potential of newly developed therapies. The MIQuant permits a standardized and simple quantification of the infarct size and therefore, its widespread use, will contribute to the systematization of the pre-clinical evaluation of novel cardiac-therapies.
2. Organic medical imaging system to detect disease and track medication — University of Nottingham — 05/10/2011
Scientists at The University of Nottingham are developing microscopic organic medical imaging systems to support a new generation of breakthrough treatments for currently incurable diseases and chronic life-threatening illnesses. The nano-transducers, made from fat found in the membrane of naturally occurring biological cells, could have a whole range of medical applications, including the potential to detect tumours earlier, monitoring electrical activity in the brain and tracking individual cells as they move around the human body.
3. High tech detection of breast cancer using nanoprobes and SQUID — BioMed Central Limited — 26/10/2011
Mammography saves lives by detecting very small tumors. However, it fails to find 10-25% of tumors and is unable to distinguish between benign and malignant disease. New research published in BioMed Central’s open access journal Breast Cancer Research provides a new and potentially more sensitive method using tumor–targeted magnetic nanoprobes and superconducting quantum interference device (SQUID) sensors.
4. Link shown between environmental toxicants and atherosclerosis — Uppsala Universitet — 05/10/2011
Environmental toxicants such as dioxins, PCBs, and pesticides can pose a risk for cardiovascular disease. For the first time a link has been demonstrated between atherosclerosis and levels of long-lived organic environmental toxicants in the blood. The study, carried out by researchers at Uppsala University, is being published online this week ahead of print in the prestigious journal Environmental Health Perspectives.
5. Novel Rapid Meningitis Diagnostic Test Moves Closer to Market — NovaUCD - The Innovation and Technology Transfer Centre at University College Dublin — 06/10/2011
Belfast Health and Social Care Trust has licensed its novel rapid meningitis diagnostic test to HiberGene Diagnostics Ltd, an Irish start-up client company of NovaUCD, the Innovation and Technology Transfer Centre at University College Dublin. The licence grants HiberGene exclusive rights to commercialise the product worldwide.